Blood Cancer Research
Written by: Emily Downward | Last reviewed: October 2019
- New drugs for treatment of blood cancers are available to Rocky Mountain Cancer Center patients, Rocky Mountain Cancer Center. Available at https://www.rockymountaincancercenters.com/new-drugs-for-treatment-of-blood-cancers-are-available-to-patients/. Accessed 2/21/18.
- Soderquist RS, Eastman A. BCL2 inhibitors as anticancer drugs: a plethora of misleading BH3 mimetics. Mol Cancer Ther. 2016 Sept; 15(9); 2011–7. doi: 10.1158/1535-7163.MCT-16-0031.
- Vannucchi AM, Harrison CN. Emerging treatments for classical myeloproliferative neoplasms. Blood. 2017 Feb;129(6):693-703. doi: 10.1182/blood-2016-10-695965.
- Furumoto Y, Gadina M. The arrival of JAK inhibitors: advancing the treatment of immune and hematologic disorders. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 2013;27(5):431-438. doi:10.1007/s40259-013-0040-7.
- CAR T cells: engineering patients’ immune cells to treat their cancers, National Cancer Institute. Available at https://www.cancer.gov/about-cancer/treatment/research/car-t-cells. Accessed 2/15/18.
- Kymriah prescribing information, Novartis Pharmaceuticals. Available at https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/kymriah.pdf. Accessed 2/16/18.
- What are cancer vaccines? American Society of Clinical Oncology Cancer.net. Available at https://www.cancer.net/navigating-cancer-care/how-cancer-treated/immunotherapy-and-vaccines/what-are-cancer-vaccines. Accessed 2/21/18.